JP2023518474A5 - - Google Patents
Info
- Publication number
- JP2023518474A5 JP2023518474A5 JP2022556583A JP2022556583A JP2023518474A5 JP 2023518474 A5 JP2023518474 A5 JP 2023518474A5 JP 2022556583 A JP2022556583 A JP 2022556583A JP 2022556583 A JP2022556583 A JP 2022556583A JP 2023518474 A5 JP2023518474 A5 JP 2023518474A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- methyl
- disease
- kit
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2004094.5A GB202004094D0 (en) | 2020-03-20 | 2020-03-20 | New compounds and uses |
| GB2004094.5 | 2020-03-20 | ||
| PCT/GB2021/050674 WO2021186180A1 (en) | 2020-03-20 | 2021-03-18 | Imidazolyl thiopehene sulfonyl carbamates for use in the treatment of diseases associated with angiotensin ii |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023518474A JP2023518474A (ja) | 2023-05-01 |
| JP2023518474A5 true JP2023518474A5 (enExample) | 2024-03-28 |
| JP7773988B2 JP7773988B2 (ja) | 2025-11-20 |
Family
ID=70546543
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022556583A Active JP7773988B2 (ja) | 2020-03-20 | 2021-03-18 | アンジオテンシンｉｉに関連する疾患の治療における使用のためのイミダゾリルチオフェンスルホニルカルバメート |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230114153A1 (enExample) |
| EP (1) | EP4121047B1 (enExample) |
| JP (1) | JP7773988B2 (enExample) |
| CN (1) | CN115666557A (enExample) |
| CA (1) | CA3174437A1 (enExample) |
| GB (1) | GB202004094D0 (enExample) |
| WO (1) | WO2021186180A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024511453A (ja) * | 2021-03-23 | 2024-03-13 | ヴィコール ファルマ アーベー | 選択的アンジオテンシンｉｉ受容体リガンド |
| WO2024133942A1 (en) | 2022-12-22 | 2024-06-27 | Vicore Pharma Ab | A method of treating a patient diagnosed with an interstitial lung disease |
| CN120569378A (zh) * | 2023-01-09 | 2025-08-29 | 维科尔药物公司 | 选择性血管紧张素ii化合物 |
| CN119504723A (zh) * | 2023-08-25 | 2025-02-25 | 武汉人福创新药物研发中心有限公司 | 作为at2r激动剂的噻吩磺酰基氨基甲酸酯 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2096883A (en) * | 1933-07-19 | 1937-10-26 | Electrolux Corp | Vacuum cleaner |
| US5312820A (en) | 1992-07-17 | 1994-05-17 | Merck & Co., Inc. | Substituted carbamoyl and oxycarbonyl derivatives of biphenylmethylamines |
| WO1994027597A1 (en) * | 1993-05-21 | 1994-12-08 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acid angiotensin ii receptor antagonists |
| US5444067A (en) | 1993-08-30 | 1995-08-22 | Merck & Co., Inc. | Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety |
| SE9800550D0 (sv) | 1998-02-24 | 1998-02-24 | A & Science Invest Ab | A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof |
| YU78601A (sh) * | 1999-05-05 | 2005-07-19 | Aventis Pharma Deutschland Gmbh. | 1-(p-tienilbenzil)-imidazoli kao agonisti angiotenzin-(1-7)- receptora, postupak za njihovu proizvodnju, njihova primena i farmaceutski preparati koji ih sadrže |
| DE60222409T2 (de) | 2001-05-31 | 2008-09-25 | Vicore Pharma Ab | Trizyklische verbindungen, nützlich als angiotensin ii agonisten |
| AU2003302106A1 (en) | 2002-11-21 | 2004-06-15 | Vicore Pharma Ab | New tricyclic angiotensin ii agonists |
| US8835471B2 (en) | 2010-06-11 | 2014-09-16 | Vicore Pharma Ab | Use of angiotensin II agonists |
| US9864250B2 (en) * | 2014-11-14 | 2018-01-09 | Heliotrope Technologies, Inc. | Post-temperable nanocrystal electrochromic devices |
| US20170266164A1 (en) | 2014-12-12 | 2017-09-21 | Vicore Pharma Ab | New methods and uses |
| WO2016107879A2 (en) | 2014-12-30 | 2016-07-07 | Vicore Pharma Ab | New use of angiotensin ii receptor agonists |
| HK1244232A1 (zh) * | 2015-03-02 | 2018-08-03 | 维科尔药物公司 | 用於治疗肺纤维化的血管紧张素ii受体激动剂 |
| WO2017221012A1 (en) | 2016-06-21 | 2017-12-28 | Vicore Pharma Ab | Methods and compositions for preventing or reducing the risk of cancer treatment-related cardiotoxicity |
| GB201710906D0 (en) | 2017-07-06 | 2017-08-23 | Vicore Pharma Ab | Compounds and methods for treating peripheral neuropathy |
| GB201913603D0 (en) * | 2019-09-20 | 2019-11-06 | Vicore Pharma Ab | New compounds |
| US11123329B1 (en) * | 2020-03-23 | 2021-09-21 | Vicore Pharma Ab | Use of angiotensin II type 2 receptor agonist |
| GB202006074D0 (en) * | 2020-04-24 | 2020-06-10 | Vicore Pharma Ab | New composition |
| GB202006079D0 (en) * | 2020-04-24 | 2020-06-10 | Vicore Pharma Ab | New composition |
| GB202201723D0 (en) * | 2022-02-10 | 2022-03-30 | Vicore Pharma Ab | New use |
| KR20240148359A (ko) * | 2022-02-10 | 2024-10-11 | 바이코어 파마 아베 | 특발성 폐섬유증 치료를 위한 불록시부티드의 용도 |
-
2020
- 2020-03-20 GB GBGB2004094.5A patent/GB202004094D0/en not_active Ceased
-
2021
- 2021-03-18 EP EP21714661.2A patent/EP4121047B1/en active Active
- 2021-03-18 CA CA3174437A patent/CA3174437A1/en active Pending
- 2021-03-18 CN CN202180021097.2A patent/CN115666557A/zh active Pending
- 2021-03-18 JP JP2022556583A patent/JP7773988B2/ja active Active
- 2021-03-18 WO PCT/GB2021/050674 patent/WO2021186180A1/en not_active Ceased
- 2021-03-18 US US17/912,645 patent/US20230114153A1/en active Pending